AMSA in a dose of 120 mg/m2 iv every 4 weeks was evaluated in 26 patients with advanced measurable colorectal cancer, 13 of whom had had no prior chemotherapy. The schedule was tolerated well except by those patients who had prior irradiation or chemotherapy, in whom a dose reduction to 90 mg/m2 was required. No significant antitumor response was observed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treatment advanced
4
advanced colorectal
4
colorectal carcinoma
4
carcinoma amsa
4
amsa amsa
4
amsa dose
4
dose 120
4
120 mg/m2
4
mg/m2 weeks
4
weeks evaluated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!